274 related articles for article (PubMed ID: 36045442)
1. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves' disease.
Tozzoli R; D'Aurizio F; Villalta D; Giovanella L
Clin Chem Lab Med; 2017 Jan; 55(1):58-64. PubMed ID: 27331310
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the diagnostic performance of thyroid-stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease.
Xu S; Shao W; Wu Q; Zhu J; Pan B; Wang B; Guo W
J Clin Lab Anal; 2023 Apr; 37(8):e24890. PubMed ID: 37161617
[TBL] [Abstract][Full Text] [Related]
5. Clinical diagnostic performance of a fully automated TSI immunoassay vs. that of an automated anti‑TSHR immunoassay for Graves' disease: a Chinese multicenter study.
Cheng X; Chai X; Ma C; Jia Q; Zhao H; Dong Z; Zhang Z; Hu Y; Song A; Yang G; Qiu L; Lian X
Endocrine; 2021 Jan; 71(1):139-148. PubMed ID: 32562184
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves' disease and predictors of responsiveness to methimazole.
Liu K; Fu Y; Li T; Liu S; Chen D; Zhao C; Shi Y; Cai Y; Yang T; Zheng X
Clin Biochem; 2021 Nov; 97():34-40. PubMed ID: 34331946
[TBL] [Abstract][Full Text] [Related]
7. Measurement of anti-TSH receptor antibodies: what is the correct cut-off value?
Smit MA; van Kinschot CMJ; van der Linden J; van Noord C; Kos S
Neth J Med; 2020 Mar; 78(2):55-63. PubMed ID: 32332174
[TBL] [Abstract][Full Text] [Related]
8. Analytical and clinical performance of newly developed immunoassay for detecting thyroid-stimulating immunoglobulin, the Immulite TSI assay.
Kim JJ; Jeong SH; Kim B; Kim D; Jeong SH
Scand J Clin Lab Invest; 2019 Oct; 79(6):443-448. PubMed ID: 31453725
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of analytic and clinical performance of two immunoassays for detecting thyroid-stimulating receptor antibody in the diagnosis of Graves' disease.
Hu Y; Ni J; Cen Y; Zhang B; Wu W; Cheng W; Huang M; Guan M
J Clin Lab Anal; 2021 Dec; 35(12):e23950. PubMed ID: 34752648
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the application of TSH receptor stimulating autoantibodies and the optimization of detection strategy in Graves' disease.
Tong M; Ding J; Huang B; Chen J; Wei X; Li Z; Shu J; Hu Z; Jiang X; Sheng H
Clin Chim Acta; 2021 Oct; 521():34-39. PubMed ID: 34144042
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two different TSH-receptor antibody assays: A clinical practice study.
van Balkum M; Schreurs MWJ; Visser WE; Peeters RP; Dik WA
Heliyon; 2023 Dec; 9(12):e22468. PubMed ID: 38107298
[TBL] [Abstract][Full Text] [Related]
12. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
[TBL] [Abstract][Full Text] [Related]
13. Analytical performance evaluation of thyroid-stimulating hormone receptor antibody (TRAb) immunoassays.
Higgins V; Patel K; Kulasingam V; Beriault DR; Rutledge AC; Selvaratnam R
Clin Biochem; 2020 Dec; 86():56-60. PubMed ID: 32858059
[TBL] [Abstract][Full Text] [Related]
14. Utility of TSH Receptor Antibodies in the Differential Diagnosis of Hyperthyroidism in Clinical Practice.
John M; Jagesh R; Unnikrishnan H; Jalaja MMN; Oommen T; Gopinath D
Indian J Endocrinol Metab; 2022; 26(1):32-37. PubMed ID: 35662753
[TBL] [Abstract][Full Text] [Related]
15. Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy.
Khamisi S; Lundqvist M; Engström BE; Larsson A; Karlsson FA; Ljunggren Ö
Exp Clin Endocrinol Diabetes; 2023 Apr; 131(4):236-241. PubMed ID: 36706788
[TBL] [Abstract][Full Text] [Related]
16. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
[TBL] [Abstract][Full Text] [Related]
17. Stimulating TSH receptor autoantibodies immunoassay: analytical evaluation and clinical performance in Graves' disease.
Autilio C; Morelli R; Locantore P; Pontecorvi A; Zuppi C; Carrozza C
Ann Clin Biochem; 2018 Jan; 55(1):172-177. PubMed ID: 28388869
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
Stan MN; Algeciras-Schimnich A; Murthy V; Thapa P; Araki N
Thyroid; 2022 Feb; 32(2):170-176. PubMed ID: 34714163
[No Abstract] [Full Text] [Related]
19. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
